Medicine Matters rheumatology

By: Springer Healthcare
  • Summary

  • Interviews with clinical experts, discussing key issues in rheumatology.
    Springer Healthcare, part of the Springer Nature group
    Show more Show less
activate_Holiday_promo_in_buybox_DT_T2
Episodes
  • Repurposing rheumatology drugs for COVID-19: TNF inhibitors (with Philip Robinson)
    Mar 9 2021

    Philip Robinson discusses why TNF inhibitors may be a favorable treatment option for COVID-19 and outlines the trials that are currently underway.

    Show more Show less
    17 mins
  • Repurposing rheumatology drugs for COVID-19: Interleukin inhibitors
    Feb 11 2021

    Cristina Mussini discusses the current data on interleukin inhibitors for the treatment of COVID-19 and explores why tocilizumab has been associated with beneficial outcomes in some studies but not others.

    Show more Show less
    19 mins
  • Repurposing rheumatology drugs for COVID-19: JAK inhibitors
    Jan 25 2021

    Marwan Bukhari talks about the rationale behind investigating baricitinib and other JAK inhibitors for the treatment of COVID-19 and outlines the current efficacy data.

    Show more Show less
    11 mins

What listeners say about Medicine Matters rheumatology

Average customer ratings

Reviews - Please select the tabs below to change the source of reviews.